Good price - well balanced between interest of current sh's and new capital providers. Well done management team. Healthnotes nearly doubles the reach of MDR so exciting times - which means I'm pretty relaxed about the new stock on issue...that's just the price you have to pay to grow your business. Deeper market penetration, new products, overseas expansion,....this has the potential of becoming really exciting real fast.
Ann: MedAdvisor Completes $8M Oversubscribed Capital Raising-MDR.AX, page-5
Add to My Watchlist
What is My Watchlist?
